查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1703287

神經假體市場－全球產業規模、佔有率、趨勢、機會和預測（按類型、技術、應用、地區和競爭細分，2020-2030 年）

Neuroprosthetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technique, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球神經假體市場價值為 134.6 億美元，預計到 2030 年將達到 274.8 億美元，預測期內年複合成長率(CAGR) 為 12.61%。在技​​術創新和不斷發展的醫療保健需求融合的推動下，這個市場正在經歷顯著擴張。

市場概覽
預測期 2026-2030
2024年市場規模 134.6億美元
2030年市場規模 274.8億美元
2025-2030 年複合年成長率 12.61%
成長最快的領域 脊髓刺激
最大的市場 北美洲

一個關鍵的成長動力是神經系統疾病盛行率的上升，例如帕金森氏症、癲癇、脊髓損傷和中風，尤其是在老年人口中。隨著這些疾病的發病率增加，對先進的、以患者為中心的神經假體解決方案的需求也在增加。

腦機介面 (BCI) 和神經植入等技術的突破為治療和復健開闢了新的途徑，改變了神經系統疾病的治療方式。公共和私營部門的資金增加以及支持性監管框架正在培育一個充滿活力的研究、開發和商業化生態系統。

關鍵市場促進因素

神經系統疾病盛行率上升

主要市場挑戰

生物相容性和安全性問題

主要市場趨勢

腦機介面（BCI）的進步

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球神經假體市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（輸出神經修復術、輸入神經修復術）
    • 依技術（脊髓刺激、深部腦部刺激、迷走神經刺激、其他技術）
    • 按應用（帕金森氏症、阿茲海默症、癲癇、聽覺處理障礙、眼科疾病、其他應用）
    • 按公司分類（2024）
    • 按地區
  • 市場地圖

第6章：北美神經假體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲神經假體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太神經假體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲神經假體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲神經假體市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Medtronic PLC
  • LivaNova PLC
  • Demant A/S
  • MED-EL Corporation
  • Cochlear Limited
  • Abbott Laboratories
  • Boston Scientific Corp
  • Second Sight Medical Products, Inc.
  • Retina Implant AG
  • NeuroPace Inc

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16258

Global Neuroprosthetics Market was valued at USD 13.46 billion in 2024 and is projected to reach USD 27.48 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.61% during the forecast period. This market is witnessing significant expansion, fueled by the convergence of technological innovation and evolving healthcare needs.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 13.46 Billion
Market Size 2030USD 27.48 Billion
CAGR 2025-203012.61%
Fastest Growing SegmentSpinal Cord Stimulation
Largest MarketNorth America

A key growth driver is the rising prevalence of neurological disorders-such as Parkinson's disease, epilepsy, spinal cord injuries, and stroke-particularly among aging populations. As the incidence of these conditions increases, so does the demand for advanced, patient-centric neuroprosthetic solutions.

Breakthroughs in technologies like brain-computer interfaces (BCIs) and neural implants are opening new avenues for treatment and rehabilitation, transforming how neurological conditions are managed. Enhanced funding from public and private sectors, along with supportive regulatory frameworks, is fostering a dynamic ecosystem for research, development, and commercialization.

Key Market Drivers

Rising Prevalence of Neurological Disorders

One of the primary drivers of growth in the neuroprosthetics market is the increasing global burden of neurological disorders. These include a wide array of conditions such as Parkinson's disease, epilepsy, Alzheimer's disease, spinal cord injuries, and stroke.

The global aging population is a significant contributor to this trend. According to the United Nations' World Population Ageing 2023 report, the number of individuals aged 65 and older is expected to rise sharply in the coming decades. For example, in the United States, the Population Reference Bureau projects that the population aged 65 and above will grow from 58 million in 2022 to 82 million by 2050-a 47% increase. Given the higher prevalence of neurodegenerative conditions among older adults, this demographic shift is expanding the potential user base for neuroprosthetic devices.

Key Market Challenges

Biocompatibility and Safety Concerns

Biocompatibility and safety remain critical challenges in the neuroprosthetics sector. These devices, which interact directly with the nervous system, must be designed to integrate seamlessly with biological tissues to prevent adverse immune responses and ensure long-term efficacy.

One major issue is the potential for immune rejection, where the body identifies the implanted device as a foreign object, leading to inflammation, discomfort, or even device failure. Ensuring that materials used are non-reactive and biocompatible is essential to mitigating these risks.

Another concern involves infection, especially with devices that include external components penetrating the skin barrier. Such infections can compromise both the function of the device and patient health, underscoring the importance of hygienic design and high-quality materials.

Long-term reliability is also paramount. Over time, device degradation due to wear, corrosion, or material fatigue can impair performance and safety. This necessitates continuous monitoring, periodic maintenance, and, in some cases, eventual replacement of the device.

Key Market Trends

Advancements in Brain-Computer Interfaces (BCIs)

Technological advancements in brain-computer interfaces (BCIs) are reshaping the neuroprosthetics landscape. BCIs facilitate direct communication between the brain and external devices, offering transformative solutions for individuals with neurological impairments.

Non-invasive BCIs, typically based on electroencephalography (EEG), are gaining traction due to their ease of use and growing accessibility. These devices allow users to interact with computers or prosthetic limbs via thought alone, without requiring surgical intervention. Their potential applications extend beyond healthcare into areas such as assistive technology, gaming, and communication.

In parallel, invasive BCIs are advancing significantly. These systems involve implanting electrodes within the brain, enabling precise data capture and neural stimulation. Innovations in electrode design, implantation techniques, and data processing have greatly improved the accuracy, safety, and durability of these systems. Invasive BCIs are being explored for applications including limb restoration, neurological therapy, and cognitive enhancement.

Emerging hybrid BCIs-combining both invasive and non-invasive elements-seek to balance precision and usability. These systems aim to deliver high-performance control while minimizing surgical risks, offering a promising middle ground for future solutions.

Key Market Players

  • Medtronic PLC
  • LivaNova PLC
  • Demant A/S
  • MED-EL Corporation
  • Cochlear Limited
  • Abbott Laboratories
  • Boston Scientific Corp
  • Second Sight Medical Products, Inc.
  • Retina Implant AG
  • NeuroPace Inc

Report Scope:

In this report, the Neuroprosthetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neuroprosthetics Market, Type:

  • Output Neural Prosthetics
  • Input Neural Prosthetics

Neuroprosthetics Market, Technique:

  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Other Techniques

Neuroprosthetics Market, Application:

  • Parkinson's Disease
  • Alzheimer's Disease
  • Epilepsy
  • Auditory Processing Disorders
  • Ophthalmic Disorders
  • Other Applications

Neuroprosthetics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Neuroprosthetics Market.

Available Customizations:

Neuroprosthetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Neuroprosthetics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Output Neural Prosthetics, Input Neural Prosthetics)
    • 5.2.2. By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Other Techniques)
    • 5.2.3. By Application (Parkinson's Disease, Alzheimer's Disease, Epilepsy, Auditory Processing Disorders, Ophthalmic Disorders, Other Applications)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Neuroprosthetics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Neuroprosthetics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
    • 6.3.2. Mexico Neuroprosthetics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
    • 6.3.3. Canada Neuroprosthetics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application

7. Europe Neuroprosthetics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Neuroprosthetics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Neuroprosthetics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Neuroprosthetics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Neuroprosthetics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Neuroprosthetics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application

8. Asia-Pacific Neuroprosthetics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Neuroprosthetics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
    • 8.3.2. India Neuroprosthetics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
    • 8.3.3. South Korea Neuroprosthetics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
    • 8.3.4. Japan Neuroprosthetics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Neuroprosthetics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application

9. South America Neuroprosthetics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Neuroprosthetics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Neuroprosthetics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Neuroprosthetics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application

10. Middle East and Africa Neuroprosthetics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Neuroprosthetics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Neuroprosthetics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Neuroprosthetics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Medtronic PLC
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. LivaNova PLC
  • 14.3. Demant A/S
  • 14.4. MED-EL Corporation
  • 14.5. Cochlear Limited
  • 14.6. Abbott Laboratories
  • 14.7. Boston Scientific Corp
  • 14.8. Second Sight Medical Products, Inc.
  • 14.9. Retina Implant AG
  • 14.10. NeuroPace Inc

15. Strategic Recommendations

16. About Us & Disclaimer